10 Apr, 2023 Nonclinical Results Exploring the Utility of RNAi and REVERSIR Technology in Modulating AAV Transgene Expression Published in Nature Communications
Posted at 08:05h
in Capella
Results from nonclinical work investigating the potential utility of combining RNAi-mediated knockdown with REVERSIR-enabled rescue of transgene expression as a rheostat for adeno-associated virus (AAV) -delivered genes in the setting of gene therapy were published in the journal Nature Communications.
